# Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

> **NCT07073326** · NA · RECRUITING · sponsor: **University of Trieste** · enrollment: 20 (estimated)

## Conditions studied

- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
- Normobaric Hypoxia

## Interventions

- **OTHER:** HYPOTRAIN
- **OTHER:** NORMOTRAIN

## Key facts

- **NCT ID:** NCT07073326
- **Lead sponsor:** University of Trieste
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-05
- **Final completion:** 2026-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07073326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07073326, "Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07073326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*